Effect of the hypolipidemic drug bezafibrate on the hepatic mixed function oxidase system of the rat: Heterogeneity monooxygenase responses
- 31 October 1981
- journal article
- Published by Elsevier BV in Pharmacological Research Communications
- Vol. 13 (9), 861-871
- https://doi.org/10.1016/s0031-6989(81)80046-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- “In vitro” metabolism of Bezafibrate by rat liverPharmacological Research Communications, 1981
- NADPH-cytochrome P-450 reductase: Preferential inhibition by ellipticine and other type II compounds having little effect on NADPH-cytochrome c reductaseBiochemical Pharmacology, 1980
- Interaction of a series of β-adrenergic blocking drugs with rat hepatic microsomal monooxygenasePharmacological Research Communications, 1979
- Nitrite binding to rabbit liver microsomes and effects on aminopyrine demethylationBiochemical Pharmacology, 1979
- Disposition pharmacokinetics of bezafibrate in manEuropean Journal of Clinical Pharmacology, 1979
- In vitro binding and metabolism of iopronic acid by rat liver microsomesPharmacological Research Communications, 1977
- Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.The Journal of cell biology, 1975
- Nature of the type I and II spectral changes in liver microsomesBiochemistry, 1970
- Evidence for Biochemically Different Types of Vesicles in the Hepatic Microsomal Fraction*The Journal of Biochemistry, 1966